Leonard A Herzenberg

This inventor holds 15 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent. Top assignees: Leland Stanford Junior University, Deutsches Krebsforschungszentrum, Other. Active years: 1985-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leonard A Herzenberg. Retrieved from https://idiyas.com/inventor/leonard-a-herzenberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15

% Patents Active = 93.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 1

Average Co-Inventor Count = 3.4

ph-index = 9

Forward Citations = 987(Granted Patents)

Location History:

Stanford, CA (US) (1985 - 2010)
Palo Alto, CA (US) (2011)

Company Filing History:

13 out of 5,509

Leland Stanford Junior University

patents

1 out of 159

Deutsches Krebsforschungszentrum

patents

2 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1985-2011

Loading Chart...

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7981625 - Prostate cancer glycan markers and autoantibody signatures (2011-07-19),

2. 7723389 - N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity (2010-05-25),

3. 7650351 - Internet-linked system for directory protocol based data storage, retrieval and analysis (2010-01-19),

4. 6947953 - Internet-linked system for directory protocol based data storage, retrieval and analysis (2005-09-20),

5. 6566401 - N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity (2003-05-20),

6. 6077665 - Rapid assay for infection in neonates (2000-06-20),

7. 5968755 - Methods for determining T-cell profiles of immunocompromised subjects (1999-10-19),

8. 5968738 - Two-reporter FACS analysis of mammalian cells using green fluorescent (1999-10-19),

9. 5843785 - Glutathione deficiency as a prognosis for survival in aids (1998-12-01),

10. 5807715 - Methods and transformed mammalian lymphocyte cells for producing (1998-09-15),

11. 5607974 - Treatment of diseases associated with cysteine deficiency (1997-03-04),

12. 5580577 - Method of treating the symptoms of human rhinovirus infection (1996-12-03),

13. 5070012 - Monitoring of cells and trans-activating transcription elements (1991-12-03),

14. 4695459 - Method of treating autoimmune diseases that are mediated by Leu3/CD4 (1987-09-22),

15. 4510244 - Cell labeling with antigen-coupled microspheres (1985-04-09),

Title: Leonard A. Herzenberg: Innovator in Cancer Research and Drug Toxicity Prevention

Introduction

Leonard A. Herzenberg is a prominent inventor based in Stanford, California. He has made significant contributions to the fields of cancer research and drug toxicity prevention. With a total of 15 patents, his work has had a profound impact on medical science.

Latest Patents

Herzenberg's latest patents include groundbreaking methods for probing immunogenic sugar moieties of prostate cancer cells. These methods detect glyco-epitopes that are highly and differentially expressed among prostate cancers of various Gleason grades. The glyco-epitopes exist on the surfaces of prostate cells and are crucial for understanding prostate cancer. Additionally, he has developed pharmaceutical compositions for the treatment and prevention of drug toxicity using N-acetylcysteine. This invention aims to mitigate the toxic effects of therapeutic agents, enhancing patient safety and treatment efficacy.

Career Highlights

Herzenberg has had a distinguished career, working at Leland Stanford Junior University, where he has contributed to various research initiatives. His innovative approaches have led to advancements in understanding cancer biology and improving therapeutic strategies.

Collaborations

Throughout his career, Herzenberg has collaborated with notable individuals such as Leonore A. Herzenberg and Vernon T. Oi. These partnerships have fostered a collaborative environment that has propelled research forward.

Conclusion

Leonard A. Herzenberg's contributions to cancer research and drug toxicity prevention exemplify the spirit of innovation in the medical field. His patents and collaborative efforts continue to influence the landscape of medical science, paving the way for future advancements.

Profile summary based on public USPTO records.